Strategic Partnerships Sobi North America leverages its rare disease focus and established patient networks to engage with patients, payers, and healthcare professionals, creating opportunities for co-developed access programs and partnerships that expand patient reach.

Biologics Manufacturing With world class protein biochemistry and biologics manufacturing capabilities, Sobi can serve as a contract development and manufacturing organization for partners developing therapies for rare diseases.

North America Footprint Established bases in Waltham, MA and Toronto position Sobi to accelerate regional market entry, clinical support, and payer engagement across the US and Canada.

Digital Health Potential The Florio GmbH partnership demonstrates openness to digital patient empowerment tools; there is potential to co-create companion apps, patient portals, and digital engagement platforms for rare-disease programs.

Market Access Strategy Sobi emphasizes listening to patients, payers, and healthcare providers to deliver value, suggesting opportunities in payer reimbursement strategies, outcomes data packages, and compliant data sharing using OneTrust and related tech to support market access.